{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:49:58Z","timestamp":1793742598345,"version":"4.6.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejogrb.2022.04.019","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T21:01:35Z","timestamp":1650920495000},"page":"90-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"273","author":[{"given":"Silvia","family":"De Rocco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Buca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-2329","authenticated-orcid":false,"given":"Ludovica","family":"Oronzii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fanfani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-0973","authenticated-orcid":false,"given":"Marco","family":"Liberati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"D'Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Leombroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Dessole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-4878","authenticated-orcid":false,"given":"Alessandro","family":"Lucidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0010","series-title":"SEER cancer statistics review, 1975\u20132015","author":"Noone","year":"2018"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3802\/jgo.2010.21.2.97","article-title":"Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia","volume":"21","author":"Salman","year":"2010","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.04.019_b0025","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.fertnstert.2012.07.1142","article-title":"Safety of uterine and\/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery","volume":"98","author":"Koskas","year":"2012","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.04.019_b0030","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.fertnstert.2009.06.013","article-title":"Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium","volume":"92","author":"Yu","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0035","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e2","article-title":"Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer","volume":"28","author":"Falcone","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0040","first-page":"13804","article-title":"Fertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young women","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.04.019_b0045","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00404-014-3417-z","article-title":"Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature","volume":"291","author":"Ohyagi-Hara","year":"2015","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.04.019_b0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/IGC.0b013e31819c5372","article-title":"Efficacy of megestrol acetate (Megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients","volume":"19","author":"Eftekhar","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.04.019_b0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/IGC.0000000000000669","article-title":"Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: a Korean Gynecologic-Oncology Group study","volume":"26","author":"Kim","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.04.019_b0065","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0015-0282(03)01183-X","article-title":"Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma","volume":"80","author":"Jadoul","year":"2003","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.019_b0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3802\/jgo.2014.25.3.214","article-title":"Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia","volume":"25","author":"Shan","year":"2014","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.019_b0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.019_b0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.04.019_b0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","article-title":"Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review","volume":"95","author":"Ramirez","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"19","key":"10.1016\/j.ejogrb.2022.04.019_b0095","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.04.019_b0100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.019_b0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijgo.12882","article-title":"A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma","volume":"146","author":"Guillon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0110","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e16","article-title":"Hysteroscopy in fertility-sparing management for early endometrial cancer: a double-edged sword","volume":"28","author":"Park","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1440-1797.2010.01380.x","article-title":"How to write a Cochrane systematic review","volume":"15","author":"Henderson","year":"2010","journal-title":"Nephrology"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0120","series-title":"Systematic reviews: CRD\u2019s guidance for undertaking reviews in health care","author":"NHS Centre for Reviews and Dissemination","year":"2009"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jclinepi.2015.09.001","article-title":"explanation and elaboration","volume":"70","author":"Welch","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0130","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0135","doi-asserted-by":"crossref","unstructured":"Zorzela L, Loke YK, Ioannidis JP, et al.; PRISMA Harms Group. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ 2016;352: i157.","DOI":"10.1136\/bmj.i157"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0140","doi-asserted-by":"crossref","unstructured":"Mazzon I, Corrado G, Masciullo V, Morricone D, Ferrandina G, Scambia G. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril 2010;93:1286\u20139.","DOI":"10.1016\/j.fertnstert.2008.12.009"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0145","doi-asserted-by":"crossref","unstructured":"Mao Y, Wan X, Chen Y, Lv W, Xie X. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma. Fertil Steril 2010;93:283\u20135.","DOI":"10.1016\/j.fertnstert.2009.07.999"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.019_b0150","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00404-011-2021-8","article-title":"Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate","volume":"285","author":"Shirali","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0155","first-page":"1934","article-title":"Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view","volume":"16","author":"Ricciardi","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.04.019_b0160","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ajo.12142","article-title":"Long-term outcomes after progestogen treatment for early endometrial cancer","volume":"53","author":"Cade","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0165","doi-asserted-by":"crossref","unstructured":"Kim MK, Seong SJ, Kim YS, et al. Combined medroxyprogesterone acetate\/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. Am J Obstet Gynecol 2013;209:358.e1\u20134.","DOI":"10.1016\/j.ajog.2013.06.031"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.12669\/pjms.292.3280","article-title":"Fertility sparing treatment in young patients with early endometrial adenocarcinoma: case series","volume":"29","author":"Jafari Shobeiri","year":"2013","journal-title":"Pak J Med Sci"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jog.12132","article-title":"Fertility outcomes of patients with early stage endometrial carcinoma","volume":"40","author":"Parlakgumus","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/AOG.0b013e31827a0643","article-title":"Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer","volume":"121","author":"Park","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2012.12.037","article-title":"Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin","volume":"129","author":"Park","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0190","doi-asserted-by":"crossref","unstructured":"Rossetti D, Bogani G, Carnelli M, Vitale SG, Grosso G, Frigerio L. Efficacy of IVF following conservative management of endometrial cancer. Gynecol Endocrinol 2014;30:280\u20131. Erratum in: Gynecol Endocrinol 2014;30:281.","DOI":"10.3109\/09513590.2014.892065"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.019_b0195","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ygyno.2015.09.078","article-title":"Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients","volume":"139","author":"Zhou","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2022.04.019_b0200","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jmig.2015.06.004","article-title":"Hysteroscopic resection in fertility-sparing surgery for atypical hyperplasia and endometrial cancer: safety and efficacy","volume":"22","author":"De Marzi","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"issue":"9","key":"10.1016\/j.ejogrb.2022.04.019_b0205","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/IGC.0000000000000825","article-title":"Long-term oncologic and reproductive outcomes in young women with early endometrial cancer conservatively treated: a prospective study and literature update","volume":"26","author":"Laurelli","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.04.019_b0210","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/IGC.0000000000001008","article-title":"Gonadotropin-releasing hormone agonist combined with a levonorgestrel-releasing intrauterine system or letrozole for fertility-preserving treatment of endometrial carcinoma and complex atypical hyperplasia in young women","volume":"27","author":"Zhou","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.04.019_b0215","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/IGC.0000000000000927","article-title":"Combined oral medroxyprogesterone\/levonorgestrel-intrauterine system treatment for women with grade 2 stage IA endometrial cancer","volume":"27","author":"Hwang","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ejogrb.2022.04.019_b0220","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/IGC.0000000000001109","article-title":"Fertility preserved hysteroscopic approach for the treatment of stage Ia endometrioid carcinoma","volume":"27","author":"Wang","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0225","doi-asserted-by":"crossref","unstructured":"Tamauchi S, Kajiyama H, Utsumi F, et al. Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer. J Obstet Gynaecol Res 2018;44:151\u20136.","DOI":"10.1111\/jog.13473"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.04.019_b0235","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jmig.2018.07.001","article-title":"Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study","volume":"26","author":"Giampaolino","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/ijgc-2018-000036","article-title":"Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer","volume":"29","author":"Chae","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.04.019_b0245","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e90","article-title":"Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients","volume":"30","author":"Mitsuhashi","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0250","doi-asserted-by":"crossref","unstructured":"Leone Roberti Maggiore U, Martinelli F, Dondi G, et al. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study. J Gynecol Oncol 2019;30:e57.","DOI":"10.3802\/jgo.2019.30.e57"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0255","doi-asserted-by":"crossref","unstructured":"Yang BY, Gulinazi Y, Du Y, et al. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial. BJOG 2020;127:848\u201357.","DOI":"10.1111\/1471-0528.16108"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0260","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.04.019_b0265","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/AOG.0b013e31826bb121","article-title":"Management of endometrial precancers","volume":"120","author":"Trimble","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0270","first-page":"72","article-title":"Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved","volume":"21","author":"Perri","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0275","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008034","article-title":"Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta-analysis and systematic review","volume":"96","author":"Wei","year":"2017","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.019_b0280","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.04.019_b0285","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2020.05.012","article-title":"Should endometrial biopsy under direct hysteroscopic visualization using the grasp technique become the new gold standard for the preoperative evaluation of the patient with endometrial cancer?","volume":"158","author":"Di Spiezio Sardo","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0290","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<139::AID-CNCR19>3.0.CO;2-U","article-title":"Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C","volume":"88","author":"Obermair","year":"2000","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.019_b0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0300","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2008.12.017","article-title":"Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma","volume":"113","author":"Leitao","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2022.04.019_b0305","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1634\/theoncologist.2013-0445","article-title":"Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer","volume":"20","author":"Park","year":"2015","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.04.019_b0310","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.fertnstert.2011.07.1146","article-title":"Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis","volume":"96","author":"Chang","year":"2011","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.04.019_b0315","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2011.01.012","article-title":"The effect of operative hysteroscopy conducted before progestin treatment in early stage endometrial cancer from the view of fertility","volume":"123","author":"Park","year":"2011","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522003189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522003189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:57:12Z","timestamp":1759557432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211522003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":63,"alternative-id":["S0301211522003189"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.04.019","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}